The laboratory automation market is projected to grow from USD 6.36 billion in 2025 to USD 9.0 billion by 2030, reflecting a CAGR of 7.2% during this period. Key drivers of this growth include the increasing demand for high-throughput screening and a shortage of experienced laboratory technicians. Automation enhances laboratory efficiency by delivering accurate results while reducing operational costs. This technological shift incorporates advancements such as artificial intelligence (AI), robotics, and machine learning. Additional factors contributing to this trend include the rising prevalence of chronic diseases and a growing interest in personalized medicine. Automation also facilitates better management of large patient sample sizes, leading to faster and more accurate diagnostics.
The market is highly competitive and characterized by rapid innovation. A competitive edge is achieved through the development of automated high-throughput systems, the integration of AI and data analytics, and improvements in speed, accuracy, and reliability. Organizations are making significant investments in research & development (R&D) to innovate and maintain their competitiveness. As a result, the market is continually evolving, with companies expanding their product offerings to meet the changing demands of laboratories in areas such as diagnostics, pharmaceuticals, and biotechnology.
To know about the assumptions considered for the study download the pdf brochure
Some of the key players in this market are Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomérieux (France), Hamilton Company (US), and Hudson Robotics (US).
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher is a leading brand in lab automation, offering a diverse range of products that include lab equipment, analytical instruments, consumables, reagents, and software solutions. The company operates in over 50 countries across North America, Europe, Asia Pacific, and Latin America. Its automation solutions encompass systems such as automated liquid handlers, ELISA analyzers, nucleic acid extractors, robotic systems, and microplate technologies. These products are primarily marketed through its Laboratory Products & Biopharma Services and Analytical Instruments segments. To expand its market share, Thermo Fisher engages in strategic acquisitions. For instance, in October 2023, it acquired Sweden's Olink Holding AB to enhance its leadership in the field of proteomics.
Tecan Group (Switzerland)
Tecan Group, based in Switzerland, is a global leader in laboratory automation, offering advanced technologies such as robotic liquid handlers, laser scanners, integrated systems, and detection modules. The company serves customers in over 52 countries and has manufacturing and research facilities in North America and Europe.
Tecan's product offerings include microplate washers, robotic arms, purification systems, and automation software. It operates through two main divisions: Life Sciences and Partnering Business. A notable recent development is the Resolve i1300 workstation, introduced in February 2024, designed to enhance workflows in personalized medicine, drug discovery, and biomarker investigation.
Market Ranking:
The lab automation market is moderately consolidated, with five major players accounting for approximately 45–60% of the global market share. Thermo Fisher Scientific holds the largest share, thanks to its extensive portfolio in life sciences, diagnostics, and applied markets, offering comprehensive automation solutions. Tecan Group Ltd. also occupies a strong position due to its high-precision liquid handling platforms and modular systems, which are designed for diagnostics and research laboratories. Danaher Corporation strengthens its market presence through its subsidiaries, such as Beckman Coulter and Molecular Devices, which are well-regarded for their scalable laboratory automation and analytical instrumentation. Agilent Technologies, Inc. is another key contributor, providing robust automation solutions for analytical laboratories, particularly in genomics, pharmaceuticals, and the chemical industry. Additionally, Roche Holding AG remains a market leader, known for its advanced clinical laboratory automation systems and the integration of digital diagnostics. The remaining 40–55% of the market is comprised of regional and niche players, creating opportunities for innovation and allowing emerging companies to establish themselves. Competition in the market is driven by the increasing demand for higher throughput, enhanced data accuracy, and seamless integration of automation into research and diagnostic workflows.
Related Reports:
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE